Pulling SEC filings + quote and writing the call…
DYN
Dyne Therapeutics, Inc.
Next earnings Jul 27, 2026 · consensus $-0.76 EPS
Last earnings +4.8% on 2026-05-11
$20.65
▲ +4.29%$19.80▲ +43.27%
over 1Y
L $8.18EODHDH $24.29
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+4.3%
1W+10.3%
1M+24.4%
3M+11.2%
YTD+7.0%
1Y+43.3%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 20 analysts
Buy
Conservative balance sheet (liabilities/equity 0.22x).
Dyne Therapeutics, Inc. shows limited reported revenue, and -45.9% ROE.
Sources: SEC EDGAR (CIK 0001818794, latest 10-Q filed 2026-05-11) · EODHD · as of 6/22/2026, 4:24:10 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.